Atrial Fibrillation: all 3,957 studies
Page 40 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.
- Flecainide-Short Long Study (Flec-SL)CompletedNCT00215774Not applicable
- Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug TherapyCompletedNCT00215761
- Treatment of Subclinical HyperthyroidismTerminatedNCT00213720
- Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial FibrillationTerminatedNCT00209911
- Long Term Open Follow-up With H376/95 vs. WarfarinTerminatedNCT00206063Phase 2
- Statin and PAF in Patients With PacemakerStatus unknownNCT00201552Not applicable
- Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass SurgeryCompletedNCT00198614Not applicable
- Cardioversion vs. Catheter Ablation for Persistent Atrial FibrillationStatus unknownNCT00196209Phase 4
- Trigger- vs. Substrate-Ablation for Paroxysmal Atrial FibrillationCompletedNCT00196183Phase 4
- Line Versus Spot Ablation in Persistent Atrial FibrillationStatus unknownNCT00196157Phase 4
- FFS - Far Field Sensing Test Study in Cardiac Dual Chamber PacemakersCompletedNCT00196144Phase 4
- A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial FibrillationCompletedNCT00192972Not applicable
- Change of Heart Rate Variability and Baroreflex Sensitivity After Ventral Cardiac DenervationStatus unknownNCT00190112Not applicable
- To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial FibrillationCompletedNCT00189319Phase 4
- Diastolic Dysfunction and Atrial Fibrillation in CABG SurgeryCompletedNCT00188903
- Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity TherapyCompletedNCT00187252Not applicable
- A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial FibrillationWithdrawnNCT00184249Not applicable
- Safety and Efficacy Study of RENEWAL 4 AVTCompletedNCT00180336Phase 2/3
- A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation MethodStatus unknownNCT00173966
- Inflammatory and Fibrotic Markers and Atrial FibrillationStatus unknownNCT00173589
- Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein GenesStatus unknownNCT00173030
- Atrial Fibrillation Feasibility Certoparin Trial - AFFECTCompletedNCT00171769Phase 3
- CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial FibrillationTerminatedNCT00170313Phase 4
- Genetic Determinants of Warfarin Anticoagulation EffectStatus unknownNCT00162435Not applicable
- CONTAK RENEWAL 3 AVTCompletedNCT00158977Phase 3
- Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac SurgeryTerminatedNCT00157807Not applicable
- LEAF - Low Energy In Atrial FibrillationCompletedNCT00157781Phase 4
- Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRTCompletedNCT00156728Phase 4
- Markers of Oxidative Stress Present in Blood in Patients With Atrial FibrillationCompletedNCT00142194
- FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)CompletedNCT00137540Phase 3
- Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial FibrillationCompletedNCT00133211Phase 3
- Candesartan in the Prevention of Relapsing Atrial FibrillationCompletedNCT00130975Phase 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126074Phase 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male SubjectsCompletedNCT00126061Phase 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126022Phase 3
- Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart SurgeryCompletedNCT00125320Phase 3
- Atrial Pacing for Termination and Prevention of Atrial FibrillationCompletedNCT00123344Not applicable
- Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and OlderTerminatedNCT00116987Not applicable
- Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory MonitoringWithdrawnNCT00115843Not applicable
- Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial FlutterCompletedNCT00115791Phase 3
- APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial FibrillationCompletedNCT00111527Phase 3
- Guidant Microwave Ablation System for the Treatment of Atrial FibrillationTerminatedNCT00111488Phase 3
- Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial FibrillationCompletedNCT00098137Phase 3
- Pharmacogenetics and Cardiovascular EventsCompletedNCT00094198
- Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications ExistCompletedNCT00075985
- Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)CompletedNCT00070655Phase 3
- Prevention Of Recurrence Of Atrial FibrillationCompletedNCT00041496Phase 2
- Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial FibrillationCompletedNCT00040001Phase 2
- Framingham Offspring Study: Psychosocial Risk FactorsCompletedNCT00037323
- Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial FibrillationCompletedNCT00035477Phase 3
- Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.CompletedNCT00035464Phase 3
- Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.CompletedNCT00035451Phase 3
- Atrial Fibrillation Incidence, Risk Factors and GeneticsCompletedNCT00021905
- Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus RhythmCompletedNCT00007605Phase 3
- Epidemiology of Symptomatic ArrhythmiasCompletedNCT00005237
- Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)CompletedNCT00000556Phase 3
- Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3